Comparing CT and MRI scans to stage newly diagnosed bladder cancer
Compares CT and MRI scans for judging how far bladder cancer has spread.
Plain-language title generated from the registry record
Registry title: Comparison of CT and MR (VI-RADS) Imaging for Local Bladder Cancer Staging
Key facts
- Where
- Oslo, NorwaySee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with newly found bladder cancer who are planned for surgery to remove the tumour or the bladder. Everyone has both a CT scan and an MRI scan.
- Age
- 18 years or older
- Sex
- All sexes can join
- Disease stage
- Newly diagnosed bladder cancer seen on cystoscopy
- Earlier treatment
- Must not have had earlier treatment for bladder cancer
Main reasons for not taking part
- Cannot have an MRI or iodinated contrast dye
- Earlier treatment for bladder cancer
- Pregnancy
- Bladder lesions that are not cancer
- Tumours in bladder diverticula
Read by machine on 9 November 2026.
Where in Norway
- Oslo University HospitalOslo, NorwayTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Oslo University Hospital
- Trial code
- NCT07602010
- Record updated
- 22 May 2026
- Original description
This prospective diagnostic accuracy study compares computed tomography (CT) and multiparametric magnetic resonance imaging (MRI) using the Vesical Imaging-Reporting and Data System (VI-RADS) for local staging of newly diagnosed bladder cancer. All participants undergo both imaging modalities prior to transurethral resection of the bladder tumor (TURBT) or cystectomy. Histopathology serves as the reference standard.Read full original descriptionShow less
Prospective Diagnostic Accuracy Study Comparing CT and MRI (VI-RADS) for Local Staging of Newly Diagnosed Bladder Cancer
This prospective diagnostic accuracy study compares computed tomography (CT) and multiparametric magnetic resonance imaging (MRI) using the Vesical Imaging-Reporting and Data System (VI-RADS) for local staging of newly diagnosed bladder cancer. All participants undergo both imaging modalities prior to transurethral resection of the bladder tumor (TURBT) or cystectomy. Histopathology serves as the reference standard.
Inclusion: Age ≥ 18 years; Newly diagnosed bladder cancer on cystoscopy; Planned TURBT or cystectomy within 6 weeks; Eligible for both CT and MRI within 6 weeks; Written informed consent provided.
Exclusion: Prior treatment for bladder cancer; Non-malignant bladder lesions; Contraindications to MRI or iodinated contrast media; Pregnancy; Tumors located in bladder diverticula.